Fullsizeoutput 664d
Fullsizeoutput 47f6

Healionics

A novel vascular graft, based on our platform STAR biomaterial, to address the critical need for improved dialysis access in patients with kidney failure.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Seattle, WA, US
  • Currency USD
  • Founded March 2007
  • Employees 7
  • Incorporation Type C-corp
  • Website healionics.com

Company Summary

Healionics is addressing the critical need for improved means of dialysis access in patients with kidney failure. We have an innovative synthetic blood vessel ready for human study and an exciting product pipeline, all based on our platform STAR biomaterial. This novel material can facilitate new types of implantable devices and improve the performance of existing ones via its unique ability to prevent both scarring and infection.

Team

  • 25 years working with early stage medical device companies in range of capacities, including entrepreneurial, venture investing, and executive roles. Co-founded several cos. early in career, including two with exits worth a combined $365M. Later led regional office for $400M VC firm, and served as CEO of one of its portfolio cos. from founding thru advanced clinicals. MBA from Stanford University, M.S. from MIT, B.S. from U.S. Naval Academy.